Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001493152-17-002765
Filing Date
2017-03-22
Accepted
2017-03-22 17:29:19
Documents
3

Document Format Files

Seq Description Document Type Size
1 form424b5.htm 424B5 418959
2 image_001.jpg GRAPHIC 2789
3 image_005.jpg GRAPHIC 22840
  Complete submission text file 0001493152-17-002765.txt   455687
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-198675 | Film No.: 17707585
SIC: 2834 Pharmaceutical Preparations